Hutchinson Institute for Cancer Outcomes Research

Research Priorities

HICOR strives to reduce the human and economic burden of cancer by conducting innovative research in the following areas:
  • Financial impact of cancer
  • Cancer outcomes
  • Cost-effectiveness research
  • Pragmatic clinical trials
  • Economic assessment of technologies and treatments
  • Cancer policy
  • Value of information
  • Cancer care delivery research

HICOR co-director Dr. Gary Lyman explains how HICOR partners with care providers, insurance companies, patient advocates, drug companies and other researchers to untangle the financial burden cancer patients face through treatment.